125 related articles for article (PubMed ID: 462583)
1. Variations in serum copper and ceruloplasmin levels in advanced gastrointestinal cancer treated with polychemotherapy.
Scanni A; Tomirotti M; Licciardello L; Annibali E; Biraghi M; Trovato M; Fittipaldi M; Adamoli P; Curtarelli G
Tumori; 1979 Jun; 65(3):331-8. PubMed ID: 462583
[TBL] [Abstract][Full Text] [Related]
2. Serum copper and ceruloplasmin levels in patients with neoplasias localized in the stomach, large intestine or lung.
Scanni A; Licciardello L; Trovato M; Tomirotti M; Biraghi M
Tumori; 1977; 63(2):175-80. PubMed ID: 898288
[TBL] [Abstract][Full Text] [Related]
3. The value of serum zinc, copper, ceruloplasmin levels in patients with gastrointestinal tract cancers.
Boz A; Evliyaoğlu O; Yildirim M; Erkan N; Karaca B
Turk J Gastroenterol; 2005 Jun; 16(2):81-4. PubMed ID: 16252197
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in advanced gastrointestinal cancer.
Scanni A; Tomirotti M; Margulis A; Biraghi M; Curtarelli G
Tumori; 1979 Feb; 65(1):111-7. PubMed ID: 87046
[TBL] [Abstract][Full Text] [Related]
5. Copper and ceruloplasmin status in serum of prostate and colon cancer patients.
Nayak SB; Bhat VR; Upadhyay D; Udupa SL
Indian J Physiol Pharmacol; 2003 Jan; 47(1):108-10. PubMed ID: 12708132
[TBL] [Abstract][Full Text] [Related]
6. Serum copper levels in gastrointestinal tract (GIT) cancer.
Narang AP; Verma A; Kumar GR; Sanyal B
J Trace Elem Electrolytes Health Dis; 1989 Sep; 3(3):147-50. PubMed ID: 2535334
[TBL] [Abstract][Full Text] [Related]
7. A trial of high-dose 5-fluorouracil with razoxane or adriamycin in the treatment of advanced adenocarcinoma of the gastrointestinal tract.
Smith BJ; Ashford RF; Bakowski M; Hellman K; Newton K; Phillips R; Lambert J; Jones R; Peters N; Evans M
Am J Clin Oncol; 1983 Aug; 6(4):481-4. PubMed ID: 6346856
[TBL] [Abstract][Full Text] [Related]
8. [Polychemotherapy associated with oral BCG in the treatment of advanced breast carcinoma. Preliminary observations of a controlled therapeutic trial].
da Silva Neto JB; Fontes CE; Varella D
AMB Rev Assoc Med Bras; 1981 Jul; 27(7):198-9. PubMed ID: 7036244
[No Abstract] [Full Text] [Related]
9. [The use of ceruloplasmin in combination with adjuvant polychemotherapy in stomach cancer].
Shchepotin IB; Chernyĭ VA; Berdinskikh NK; Sanina OL; Baraboĭ VA; Starosel'skiĭ IV; Korobko VB; Kamenets LIa; Iaremenko LIa
Vrach Delo; 1991 Mar; (3):24-7. PubMed ID: 2042339
[TBL] [Abstract][Full Text] [Related]
10. Systemic chemotherapy for advanced gastrointestinal cancer.
Bedikian AY; Valdivieso M; Bodey GP
South Med J; 1980 Aug; 73(8):1046-52. PubMed ID: 6996103
[TBL] [Abstract][Full Text] [Related]
11. Significance of methotrexate serum level achieved in patients with gastrointestinal malignancies treated with sequential methotrexate, L-folinic acid and 5-fluorouracil.
Comella P; Palmieri G; Beneduce G; Casaretti R; Daponte A; Gravina A; Frasci G; Biondi E; Comella G
Oncology; 1996; 53(3):198-203. PubMed ID: 8643221
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with 5-fluorouracil and methyl-CCNU for the treatment of advanced gastrointestinal cancer.
Brutti A; Liberati AM; Biscottini B; Fatati G; Sini S; Barzi AM; Grignani F
Tumori; 1979 Jun; 65(3):339-44. PubMed ID: 462584
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced gastrointestinal malignancy.
Vaughn CB; Chapman JL; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Brady PR
Oncology; 1981; 38(3):129-33. PubMed ID: 7010257
[TBL] [Abstract][Full Text] [Related]
14. Serum ceruloplasmin and copper levels in patients with primary brain tumors.
Turecký L; Kalina P; Uhlíková E; Námerová S; Krizko J
Klin Wochenschr; 1984 Feb; 62(4):187-9. PubMed ID: 6323815
[TBL] [Abstract][Full Text] [Related]
15. [Effect of antiblastic polychemotherapy (CMF) on the number of circulating monocytes in patients with breast cancer].
Bariani L; Dolcetti U; Indelli M; Gualandi G; Malacarne P; Castaldi G
Minerva Med; 1982 Oct; 73(39):2641-8. PubMed ID: 7121879
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
[No Abstract] [Full Text] [Related]
17. [Chemotherapy in curable breast cancer].
Seradour B; Thomas M
J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):175-82. PubMed ID: 353124
[No Abstract] [Full Text] [Related]
18. Serum transferrin and ceruloplasmin in patients with cancer of the gastrointestinal and other systems.
Agroyannis B; Dalamangas A; Dardouphas K; Fortoynas C; Saloum G; Stringou E; Tzanatos H; Koutsikos D; Papadimitriou J
Anticancer Res; 1994; 14(5B):2201-3. PubMed ID: 7840524
[TBL] [Abstract][Full Text] [Related]
19. [Effect of polychemotherapy of cancer of the digestive organs].
Singer Z; Kobylińska-Scieszkowa M; Dzieza-Lalowicz I; Starzewska H; Rogoń Z; Gejsler A
Pol Tyg Lek; 1980 Sep; 35(38):1453-5. PubMed ID: 7465441
[No Abstract] [Full Text] [Related]
20. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
